A chitosan-based cascade-responsive drug delivery system for triple-negative breast cancer therapy

被引：0
|
作者：
Shiwei Niu
Gareth R. Williams
Jianrong Wu
Junzi Wu
Xuejing Zhang
Xia Chen
Shude Li
Jianlin Jiao
Li-Min Zhu
机构：
[1] Donghua University,College of Chemistry, Chemical Engineering and Biotechnology
[2] University College London,UCL School of Pharmacy
[3] Yunnan University of Traditional Chinese Medicine,School of Basic Medicine
[4] Kunming Medical University,Department of Biochemistry and Molecular Biology, School of Basic Medicine
[5] Kunming Medical University,Technology Transfer Center
来源：
Journal of Nanobiotechnology | / 17卷
关键词：
Chitosan; Doxorubicin; Triple-negative breast; Cascade responsive; Cell penetrating peptide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Albumin-Coated Framework Nucleic Acids as Bionic Delivery System for Triple-Negative Breast Cancer Therapy
    Zhang, Yuxin
    Mao, Chenchen
    Zhan, Yuxi
    Zhao, Yuxuan
    Chen, Ye
    Lin, Yunfeng
    ACS APPLIED MATERIALS & INTERFACES, 2022, 14 (35) : 39819 - 39829
  • [42] Screening of Polymer-Based Drug Delivery Vehicles Targeting Folate Receptors in Triple-Negative Breast Cancer
    Das, Dola
    Koirala, Nischal
    Li, Xin
    Khan, Nadia
    Dong, Franklin
    Zhang, William
    Mulay, Prajakatta
    Shrikhande, Gayatri
    Puskas, Judit
    Drazba, Judy
    McLennan, Gordon
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2020, 31 (11) : 1866 - +
  • [43] Drug self-delivery nanorods enhance photodynamic therapy of triple-negative breast cancer by inhibiting oxidative phosphorylation
    Gao, Wenhao
    Zhang, Jialiang
    Wang, Weifeng
    Liu, Zhihong
    Chen, Mulan
    Hu, Xiaomu
    Zeng, Lingjun
    Zheng, Changqing
    Song, Hongtao
    Zhang, Qian
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2022, 621
  • [44] Developments in drug therapy for triple-negative breast cancer Update gynecologic oncology 2021
    Fink, A.
    De Gregorio, A.
    Braun, T.
    Ernst, K.
    Huober, J.
    Fink, V.
    Janni, W.
    Rack, B.
    ONKOLOGE, 2021, 27 (07): : 697 - 702
  • [45] Hypoxia-Targeted Responsive Delivery of Doxorubicin and Digoxin for Synergistic Treatment of Triple-Negative Breast Cancer
    Weng, Lingyan
    Zhao, Min
    Chen, Zhongping
    Zhu, Li
    MOLECULAR PHARMACEUTICS, 2025, 22 (04) : 2142 - 2158
  • [46] Research progress of paclitaxel nanodrug delivery system in the treatment of triple-negative breast cancer
    Qiao, Jia-xin
    Guo, Dong-yan
    Tian, Huan
    Wang, Zhan-peng
    Fan, Qiang-qiang
    Tian, Yuan
    Sun, Jing
    Zhang, Xiao-fei
    Zou, Jun-bo
    Cheng, Jiang-xue
    Luan, Fei
    Zhai, Bing-tao
    MATERIALS TODAY BIO, 2024, 29
  • [47] The role of the immune system in triple-negative breast cancer
    Cvetka, Grasic Kuhar
    ONKOLOGIJA, 2020, 24 (01) : 32 - 38
  • [48] Bioinformatic analysis of drug targets for triple-negative breast cancer
    Li, Xiao-Wei
    Kang, Chun-Bo
    Chi, Xiao-Qian
    Liu, Tie-Jun
    ASIAN JOURNAL OF SURGERY, 2023, 46 (02) : 882 - 883
  • [49] Stimuli-responsive chitosan-based nanocarriers for cancer therapy
    Fathi, Marziyeh
    Zangabad, Parham Sahandi
    Majidi, Sima
    Barar, Jaleh
    Erfan-Niya, Hamid
    Omidi, Yadollah
    BIOIMPACTS, 2017, 7 (04) : 269 - 277
  • [50] Is the future of personalized therapy in triple-negative breast cancer based on molecular subtype?
    Le Du, Fanny
    Eckhardt, Bedrich L.
    Lim, Bora
    Litton, Jennifer K.
    Moulder, Stacy
    Meric-Bernstam, Funda
    Gonzalez-Angulo, Ana M.
    Ueno, Naoto T.
    ONCOTARGET, 2015, 6 (15) : 12890 - 12908
12345